1. Home
  2. SGBX vs SYBX Comparison

SGBX vs SYBX Comparison

Compare SGBX & SYBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Safe & Green Holdings Corp.

SGBX

Safe & Green Holdings Corp.

HOLD

Current Price

$4.00

Market Cap

18.1M

ML Signal

HOLD

Logo Synlogic Inc.

SYBX

Synlogic Inc.

HOLD

Current Price

$1.13

Market Cap

15.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SGBX
SYBX
Founded
2007
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
RETAIL: Building Materials
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.1M
15.2M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
SGBX
SYBX
Price
$4.00
$1.13
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
18.7M
32.7K
Earning Date
11-14-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,382,896.00
N/A
Revenue This Year
$1,628.82
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.81
$0.90
52 Week High
$122.88
$1.96

Technical Indicators

Market Signals
Indicator
SGBX
SYBX
Relative Strength Index (RSI) 54.87 20.66
Support Level $2.91 $1.58
Resistance Level $4.04 $1.73
Average True Range (ATR) 1.40 0.09
MACD 0.06 -0.05
Stochastic Oscillator 26.04 7.58

Price Performance

Historical Comparison
SGBX
SYBX

About SGBX Safe & Green Holdings Corp.

Safe & Green Holdings Corp is a modular solutions company. The company currently provides modules made out of both code-engineered cargo shipping containers and wood for use as both permanent or temporary structures for residential housing use and commercial use, including for health care facilities. It operates in four segments: construction services; medical; real estate development; and environmental. The company generates the majority of its revenue from the Construction segment includes the company's manufacturing unit SG ECHO and other modules projects.

About SYBX Synlogic Inc.

Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.

Share on Social Networks: